Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections

22. October 2021

Intestinal Pseudomonas aeruginosa is highly problematic in immunocompromised patients such as those in intensive care units in hospitals. Phage therapy is an attractive alternative or...

UNGAP best practice for improving solubility data quality of orally administered drugs

21. October 2021

An important goal of the European Cooperation in Science and Technology (COST) Action UNGAP (UNderstanding Gastrointestinal Absorption-related Processes, www.ungap.eu) is...

Figure 8 Cause–effect diagram of ODTs preparation.

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method

21. October 2021

Purpose: This study aimed to formulate an orally disintegrating tablet (ODT) containing both baclofen and meloxicam together for treating osteoarthritis....

ADM-SIO Pharmaceutical oils for CBD_THC_Hemp

Pharmaceutical oils for Cannabinoid drug products from ADM-SIO

20. October 2021

Medicinal Cannabinoids There are currently more than 150 cannabinoid-based products under development in the world. The first US FDA approved...

Gelucire® 59/14, solid surfactant for oral bioavailability enhancement

18. October 2021

Gattefossé widens its range of functional excipients for oral bioavailability enhancement with a new grade of Gelucire®: Gelucire® 59/14, a...

graphical abstract of Simultaneous determination of third-generation synthetic cannabinoids in oral fluids using cyclodextrin-silica porous sorbents

Simultaneous determination of third-generation synthetic cannabinoids in oral fluids using cyclodextrin-silica porous sorbents

15. October 2021

A microporous material made of cyclodextrin units covalently immobilized into a silica network has found an innovative bioanalytical application in...

Oral Excipients